Erik Helgstrand
About
In The Last Decade
Erik Helgstrand
19 papers receiving 539 citations
Peers
Comparison fields: 5 of 72
- Epidemiology 315
- Molecular Biology 210
- Infectious Diseases 210
- Organic Chemistry 113
- Immunology 72
Countries citing papers authored by Erik Helgstrand
This map shows the geographic impact of Erik Helgstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Helgstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Helgstrand more than expected).
Fields of papers citing papers by Erik Helgstrand
This network shows the impact of papers produced by Erik Helgstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Helgstrand. The network helps show where Erik Helgstrand may publish in the future.
Co-authorship network of co-authors of Erik Helgstrand
This figure shows the co-authorship network connecting the top 25 collaborators of Erik Helgstrand. A scholar is included among the top collaborators of Erik Helgstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Helgstrand. Erik Helgstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 52 | |
| 3 | Inhibition of hepatitis B Dane particle DNA polymerase activity by pyro-phosphate analogs. | 13 |
| 4 | 68 | |
| 5 | 19 | |
| 6 | Experimental studies on the antiherpetic agent phosphonoformic acid. | 5 |
| 7 | 18 | |
| 8 | 12 | |
| 9 | 175 | |
| 10 | 215 | |
| 11 | Potential hypolipidemic agents. V. Syntheses of some new 3-substituted pyridines. Effects on noradrenaline-stimulated free fatty acid mobilization. | 1 |
| 12 | Potential hypolipidemic agents. I. Syntheses of esters related to 5-fluoro- and 5-chloronicotinic acid and the corresponding alcohols. Effects on noradrenaline-stimulated free fatty acid mobilization. | 1 |
| 13 | 2 | |
| 14 | Potential hypolipidemic agents. 3. Heterocyclic compounds affecting free fatty acid mobilization in vivo. | 1 |
| 15 | 3 | |
| 16 | 16 | |
| 17 | 2 | |
| 18 | 1 | |
| 19 | 2 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.